Skip to content
Screener

Abbott ABT Q4 2025 Annual earnings

Reported January 22, 2026 · Before market open

Revenue$11.5BMiss by $341.5M
EPS$1.50In line
Revenue estimate$11.8B
EPS estimate$1.50

Next report

Oct 21, 2026 (In 2 weeks)
Revenue estimate$13.0B
EPS estimate$1.42

Financials

Q4 2025

Income statement

See full
Revenue$11.5B+4.4%
Gross profit$6.5B+8.4%
Operating income$2.3B+17.8%
Net income$1.8B-80.8%
EPS (diluted)$1.02-80.6%

Balance sheet

See full
Cash & equivalents$8.5B+11.9%
Total debt$14.1B-7.5%
Total equity$52.1B+9.4%
Total assets$86.7B+6.5%

Cash flow

See full
Operating cash flow$3.3B+15.6%
CapEx$689.0M-4.3%
Free cash flow$2.6B+22.3%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$217.86B+11.1%
Enterprise value$223.48B+9.6%
P/E33.4×+18.8×
P/S4.9×+0.2×

Profitability

See full
Gross margin56.4%+1.0pp
Operating margin18.2%+1.9pp
Net margin14.7%-17.2pp
FCF margin16.7%+1.5pp

Returns & leverage

See full
Return on equity13.1%-18.0pp
Debt / equity0.3×0.0×
Current ratio1.6×-0.1×

Segments

By segment

See full
Medical Devices$5.7B+12.3%
Diagnostic Products$2.5B-2.5%
Nutritional Products$1.9B-8.9%
Established Pharmaceuticals$1.4B+9.0%

FAQ

When did Abbott report Q4 2025 earnings?
Abbott (ABT) reported Q4 2025 earnings on January 22, 2026 before market open.
What were Abbott's Q4 2025 revenue and EPS?
Abbott reported revenue of $11.5B and eps of $1.50 for Q4 2025.
Did Abbott beat estimates in Q4 2025?
Revenue missed the consensus estimate of $11.8B by $341.5M. EPS beat the consensus estimate of $1.50 by $0.00.
How did Abbott's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 4.4% from $11.0B a year earlier and eps grew 11.9% from $1.34.
Where can I find Abbott's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001628280-26-002982) and the 10-K periodic report (0001628280-26-010185) directly on SEC EDGAR. The filing index links above go to sec.gov.